Call (844) 879-2237

Request additional information regarding Cerafix®

A Material Development Company

A bioscience company commercializing a portfolio of fully synthetic electrospun scaffolds for regenerative medical applications

Feature image

The FDA cleared Acera’s first product in March 2016 and its second product in April 2017, both via 510(k). Acera is currently raising Series A financing, as well as seeking strategic partners for product development and commercialization.

Feature image
Cytrell™

The Theme had a simple layout which attracts the Client to the Website. Also, the professional and Clean design .

Feature image
Acera Meshes
Biologic Properties

The Theme had a simple layout which attracts the Client to the Website. Also, the professional and Clean design .

Feature image
Acera Performance
Investment Opportunities

The Theme had a simple layout which attracts the Client to the Website. Also, the professional and Clean design .

Acera News

Acera to Start Clinical Trial on Restrata™ Wound Matrix

St. Louis, MO. September 15, 2017- Acera is starting a clinical trial on on Restrata™ Wound Matrix  with a focus on diabetic foot ulcer.  Acera will be working with work with Telos Partner to manage the clinical trial.The study is […]

Read More

Acera Surgical Announces Publication of Pre-Clinical Study on Restrata™

St. Louis, MO—September 5, 2017— Acera Surgical Inc., a company dedicated to the development and commercialization of fully synthetic electrospun scaffolds for regenerative medical applications, announced today the publication of results from the pre-clinical study of the efficacy of Restrata […]

Read More